"The risk of developing these severe side effects is very small, but it is important that patients and healthcare professionals are aware and alert to the associated symptoms." In the UK, the most commonly used GLP-1 therapies are Novo Nordisk's semaglutide-based Ozempic for diabetes and Wegovy for obesity, as well as Eli Lilly's Mounjaro (tirzepatide), which are all given as weekly injections
Immunologically, allergen sIgE levels, IL-4, and IL-13 levels were decreased and IFN- levels were increased in FAHF-2 -treated mice (Fig
Costantino, L
Anything that pulls the system back toward equilibrium
However, a major federal initiative could change this in 2027: CMS BALANCE Model: GLP-1 Coverage Expansion On December 23, 2025, CMS announced the BALANCE Model (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth)a voluntary program that would cover GLP-1s for weight loss through participating Medicare Part D and Medicaid plans
ROS could impair mitochondrial DNA, ETC., and damage mitochondrial membrane, further leading to more production of ROS (Szczepanowska et al., 2012